ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The effect of perioperative of dexamethasone on postoperative complications after pancreaticoduodenectomy (PANDEX): a study protocol for a pragmatic multicenter randomized controlled trial

Chen, Haoda; Wang, Ying; Wang, Chao; Lu, Xiaojian; Li, Yilong; Sun, Bei; Jiang, Kuirong; Qiu, Yudong; Chen, Rufu; Cao, Liping; Chen, Shi; Luo, Yan*; Shen, Baiyong*广东省人民医院; 南京大学; 上海交通大学; 哈尔滨医科大学; 浙江大学; 1; y
Trials2023-9-2DOI: 10.1186/s13063-023-07571-y
5阅读
引用收藏
分享

摘要

BackgroundPancreaticoduodenectomy (PD) nowadays serves as a standard treatment for patients with disorders of the pancreas, intestine, and bile duct. Although the mortality rate of patients undergoing PD has decreased significantly, postoperative complication rates remain high. Dexamethasone, a synthetic glucocorticoid with potent anti-inflammatory and metabolic effects, has been proven to have a favorable effect on certain complications. However, the role it plays in post-pancreatectomy patients has not been systematically evaluated. The aim of this study is to assess the effect of dexamethasone on postoperative complications after PD.MethodsThe PANDEX trial is an investigator-initiated, multicentric, prospective, randomized, double-blinded, placebo-control, pragmatic study. The trial is designed to enroll 300 patients who are going to receive elective PD. Patients will be randomized to receive 0.2 mg/kg dexamethasone or saline placebo, administered as an intravenous bolus within 5 min after induction of anesthesia. The primary outcome is the Comprehensive Complication Index (CCI) score within 30 days after the operation. The secondary outcomes include postoperative major complications (Clavien-Dindo & GE;3), postoperative pancreatic fistula (POPF), post-pancreatectomy acute pancreatitis (PPAP), infection, and unexpected relaparotomy, as well as postoperative length of stay, 30-day mortality, and 90-day mortality.DiscussionThe PANDEX trial is the first randomized controlled trial concerning the effect of dexamethasone on postoperative complications of patients undergoing PD, with the hypothesis that the intraoperative use of dexamethasone can reduce the incidence of postoperative complications and improve short-term outcomes after PD. The results of the present study will guide the perioperative use of dexamethasone and help improve the clinical management of post-pancreatectomy patients.Trial registrationClinicalTrials.gov NCT05567094. Registered on 30 September 30 2022

学科与关键词

关键词
PancreaticoduodenectomyDexamethasonePostoperative complications
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Trials
发表日期
2023-09-02
卷期
第 24 卷, 第 1 期
页码
569
DOI
10.1186/s13063-023-07571-y
语言
ENGLISH
成果收录
SCIE
资助标注
Ruijin Youth National Science Foundation Cultivation Fund [KY2022668]

作者

  • C

    Chen, Haoda (第一作者)

    ruijin hosp · shanghai jiao tong univ

  • W

    Wang, Ying

    ruijin hosp · shanghai jiao tong univ

查看全部 13 位作者收起作者
  • W

    Wang, Chao

    ruijin hosp · shanghai jiao tong univ

  • L

    Lu, Xiaojian

    ruijin hosp · shanghai jiao tong univ

  • L

    Li, Yilong

    1 · harbin med univ

  • S

    Sun, Bei

    1 · harbin med univ

  • J

    Jiang, Kuirong

    1 · nanjing med univ

  • Q

    Qiu, Yudong

    nanjing univ

  • C

    Chen, Rufu

    guangdong prov peoples hosp

  • C

    Cao, Liping

    zhejiang univ

  • C

    Chen, Shi

    fujian med univ · fujian prov hosp

  • L

    Luo, Yan (通讯)

    ruijin hosp · shanghai jiao tong univ

  • S

    Shen, Baiyong (通讯)

    ruijin hosp · shanghai jiao tong univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417